Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126396541 | 12639654 | 1 | I | 201605 | 20160729 | 20160810 | 20160810 | EXP | US-ACCORD-042940 | ACCORD | 81.00 | YR | M | Y | 80.70000 | KG | 20160810 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126396541 | 12639654 | 1 | PS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | U | 203154 | TABLET | |||||||||
126396541 | 12639654 | 2 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | ALSO RECEIVED AT 15 MG BID ORALLY ON APR-2016 | 0 | 5 | MG | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126396541 | 12639654 | 1 | Product used for unknown indication |
126396541 | 12639654 | 2 | Polycythaemia vera |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126396541 | 12639654 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126396541 | 12639654 | Blister | |
126396541 | 12639654 | Fatigue | |
126396541 | 12639654 | Oedema peripheral | |
126396541 | 12639654 | Pancytopenia | |
126396541 | 12639654 | Splenomegaly |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126396541 | 12639654 | 2 | 20150406 | 0 |